13-cis-retinoic acid in the treatment of
โ
Zachary B. Kramer; Laszlo Boros; Peter H. Wiernik; Janet Andersen; John M. Benne
๐
Article
๐
1991
๐
John Wiley and Sons
๐
English
โ 297 KB
๐ 2 views
The management of acute myeloid leukemia in the elderly (65 years and older) is unsatisfactory because of poor patient tolerance of standard myeloablative chemotherapy. The authors conducted a Phase II study to evaluate the effectiveness and toxicity of 13-cis-retinoic acid (CRA) in the therapy of e